Audio

Scientists use innovative stem cell culture models to progress retinal cell therapy research.

Scientists advance Parkinson’s disease biomarker research one sniff at a time.

Josephine Thinwa shares her journey to becoming a physician scientist and how this led her to investigate the role of a neurologically important kinase in virus-induced autophagy.

Alex Mohr discusses a trial comparing various calorie-restricted diets on the gut microbiome and overall health measures.

In this podcast series, scientists discuss the unique ways they employ synthesized DNA libraries in their research. 

As a trailblazer in rare disease research and treatment, Wendy Chung captures the big picture of rare disease genetics with the help of next generation sequencing.

Walker Inman explains the importance of monitoring cells in culture.

Researchers take brain training to the next level by launching mini brains into outer space.

Nardhy Gómez-López investigates the placental immunology of preterm birth.

Lukas Chavez uses multiomic techniques to study how extrachromosomal DNA (ecDNA) contributes to tumor heterogeneity and gene expression changes in medulloblastoma.

Paola Arlotta discussed her journey to become a leader in brain organoid research.

Researchers tackle the antibiotic resistance crisis with explainable neural networks and high throughput drug discovery.

Researchers explore the trippy science behind natural hallucinogens in humans. 

Jonathan Weissman and Luke Gilbert share how they developed several CRISPR-based epigenetic editors and how these tools differ from traditional CRISPR.

Scientists discuss the advent of robotically run research and the new era of academic cloud labs on the horizon.

Lauren Drouin shares how personal connections and scientific curiosities drive her work on gene therapy viral vectors. 

Filippo Rossignoli discusses the challenges he faced when employing lentiviruses to produce immunotherapies and how he overcame these obstacles.

Researchers get creative using bacterial bits and pieces to produce synthetic cells for studying cancer.

Neurobiologists, computer scientists, and engineers join forces to grow mini brains using automation and make their technologies smarter with artificial intelligence.